John K. Scott Jr. - Jun 1, 2023 Form 4 Insider Report for NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB)

Role: Director, 10%+ Owner
Signature: /s/ Joseph W. Meyer for John K. Scott, Jr. by power of attorney
Stock symbol: NAVB
Transactions as of: Jun 1, 2023
Transactions value $: $0
Form type: 4
Date filed: 6/15/2023, 06:35 PM
Previous filing: Nov 30, 2022
Next filing: Jun 30, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NAVB	Series G Redeemable Preferred Stock	Other		-990	-30.37%		2.27K	Jun 1, 2023	Direct	F1
transaction	NAVB	Common Stock	Award		+11.5M	+143.02%		19.6M	Jun 5, 2023	Direct	F2
holding	NAVB	Common Stock						10.1K	Jun 1, 2023	By spouse and children	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NAVB	Series J Convertible Preferred Stock	Purchase	$1.2M	+12K		$100.00^*	12K	Jun 1, 2023	Common Stock	11.5M	$0.10	Direct	F1, F4
transaction	NAVB	Series J Convertible Preferred Stock	Conversion of derivative security	-$1.2M	-12K	-100%	$100.00^*	0	Jun 5, 2023	Common Stock	11.5M	$0.10	Direct	F4, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Navidea entered into a Stock Exchange Agreement with the Reporting Person, pursuant to which he surrendered 990 shares of Series G Redeemable Preferred Stock, par value $.001 per share, and $68,853.22 of accrued and unpaid dividends thereon in exchange for 11,969 shares of Series J Convertible Preferred Stock, par value $.001 per share.
F2	Series J Convertible Preferred Stock, par value $.001 per share was converted into Common Stock.
F3	Includes 2,639 shares of Common Stock owned by the Reporting Person's spouse and 7,500 shares of Common Stock owned by the Reporting Person's children. The Reporting Person may be deemed tohave shared voting and/or dispositive power with respect to such shares.
F4	Series J Convertible Preferred Stock, par value $.001 per share, is convertible at any time and has no expiration date.
F5	The Reporting Person converted 11,969 shares of Series J Convertible Preferred Stock, par value $.001 per share, into 11,508,672 shares of Common Stock.